IDELALISIB 150 MG TABLET

🧪 Composition

• Active Ingredient: Idelalisib
• Dosage Form: Oral Tablet
• Strength: 150 mg

✅ Uses

• Used in the treatment of Relapsed Chronic Lymphocytic Leukemia (CLL) in appropriate patients.
• Indicated for certain cases of Follicular Lymphoma (FL) after prior therapies.
• Used in selected patients with Small Lymphocytic Lymphoma (SLL) as recommended by a healthcare professional.
• Helps slow the growth and survival of abnormal lymphocytes.

💉 Dosage

Take Idelalisib 150 mg exactly as prescribed by your healthcare provider. The dosage and duration of treatment depend on the patient’s medical condition, previous therapies, and response to treatment. Swallow the tablet whole with water and follow your physician’s instructions carefully.

⚠️ Precautions

• Use only under the supervision of a qualified healthcare professional.
• Regular monitoring of liver function, blood counts, and signs of infection is recommended during treatment.
• Inform your doctor about any liver disease, lung disorders, intestinal problems, or ongoing infections before starting therapy.
• Contact your healthcare provider immediately if you experience severe diarrhea, fever, breathing difficulties, or unusual bruising or bleeding.

📦 Storage

Store the tablets at room temperature in a cool, dry place away from heat, moisture, and direct sunlight. Keep the medicine in its original packaging and out of the reach of children.

⭐ Conclusion

Idelalisib 150 mg is an effective targeted therapy for eligible patients with selected B-cell blood cancers, including Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma (FL), and Small Lymphocytic Lymphoma (SLL). When used under specialist supervision and with regular monitoring, it can help manage disease progression and support improved treatment outcomes. Always follow your healthcare provider’s recommendations for safe and effective use.